The Positive Effects of Different Platelet-Rich Plasma Methods on Human Muscle, Bone, and Tendon Cells
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Clinical application of platelet-rich plasma (PRP) in the realm of orthopaedic sports medicine has yielded variable results. Differences in separation methods and variability of the individual may contribute to these variable results. Purpose: To compare the effects of different PRP separation methods on human bone, muscle, and tendon cells in an in vitro model. Study Design: Controlled laboratory study. Methods: Blood collected from 8 participants (mean ± SD age 31.6 ± 10.9 years) was used to obtain PRP preparations. Three different PRP separation methods were used: a single-spin process yielding a lower platelet concentration (PRP LP), a single-spin process yielding high platelet and white blood cell concentrations (PRP HP), and a double-spin that produces a higher platelet concentration and lower white blood cell concentration (PRP DS). Human bone, muscle, and tendon cells obtained from discarded tissue samples during shoulder surgery were placed into culture and treated with the 3 PRP preparations, control media (2% fetal bovine serum [FBS] and 10% FBS), and native blood. Radioactive thymidine assays were obtained to examine cell proliferation, and testing with enzyme-linked immunosorbent assay was used to determine growth factor concentrations. Results: Addition of PRP LP to osteocytes, myocytes, and tenocytes significantly increased cell proliferation ( P ≤ .05) compared with the controls. Adding PRP DS to osteoblasts and tenocytes increased cell proliferation significantly ( P ≤ .05), but no significance was shown for its addition to myocytes. The addition of PRP HP significantly increased cell proliferation compared with the controls only when added to tenocytes ( P ≤ .05). Osteoblasts: Proliferation was significantly increased by addition of PRP LP compared with all controls (2% FBS, 10% FBS, native blood) ( P ≤ .05). Addition of PRP DS led to significantly increased proliferation compared with all controls, native blood, and PRP HP ( P ≤ .05). Proliferation was significantly less when PRP HP was added compared with PRP DS ( P ≤ .05). Myocytes: Proliferation was significantly increased by addition of PRP LP compared with native blood ( P ≤ .05). Adding PRP HP or PRP DS to myocytes showed no significant increase in proliferation compared with the controls or the other separations. Tenocytes: Proliferation was significantly increased by addition of PRP LP compared with all controls (2% FBS, 10% FBS, native blood) ( P ≤ .05). Addition of PRP DS showed a significant increase compared with the controls and native blood. For tenocytes, there was a significant increase ( P ≤ .05) seen when PRP HP was added compared with the controls and native blood but not compared with the other separations. Conclusion: The primary findings of this study suggest the application of different PRP separations may result in a potential beneficial effect on the clinically relevant target cells in vitro. However, it is unclear which platelet concentration or PRP preparation may be optimal for the treatment of various cell types. In addition, a “more is better” theory for the use of higher platelet concentrations cannot be supported. This study was not intended to prove efficacy but to provide a platform for future research to be built upon. Clinical Relevance: The utilization of different PRP separations may result in a potentially beneficial effect on the clinically relevant target cells in vitro, but it is unclear which platelet concentration or PRP preparation may be optimal for the treatment of various cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can Platelet-Rich Plasma Enhance Tendon Repair?: A Cell Culture Study
de Mos, M., van der Windt, A. E., Jahr, H., van Schie, H. T. M., Weinans, H., Verhaar, J. A. N., & van Osch, G. J. V. M. (2008) · The American Journal of Sports Medicine · doi:10.1177/0363546508314430 · Cited by 423
Carofino, B., Chowaniec, D. M., McCarthy, M. B., Bradley, J. P., Delaronde, S., Beitzel, K., Cote, M. P., Arciero, R. A., & Mazzocca, A. D. (2012) · Arthroscopy · doi:10.1016/j.arthro.2011.09.013 · Cited by 147
Self-citationFallouh, L., Nakagawa, K., Sasho, T., Arai, M., Kitahara, S., Wada, Y., Moriya, H., & Takahashi, K. (2010) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/jbjs.i.01158 · Cited by 71
Cited by
Amable, P. R., Carias, R. B. V., Teixeira, M. V. T., da Cruz Pacheco, Í., Corrêa do Amaral, R. J. F., Granjeiro, J. M., & Borojevic, R. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt218 · Cited by 725
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T., Strunk, D., Koh, M. B. C., & Schallmoser, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.065 · Cited by 521
Platelet-rich plasma for managing pain and inflammation in osteoarthritis
Andia, I., & Maffulli, N. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.141 · Cited by 465
Yan, R., Gu, Y., Ran, J., Hu, Y., Zheng, Z., Zeng, M., Heng, B. C., Chen, X., Yin, Z., Chen, W., et al. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517694357 · Cited by 124
“The optimal platelet concentration of PRP for tissue repair and regeneration is thought to be 3 to 5 times higher than that of whole blood, while higher concentrations impair the anabolic effects.(24,38,39) Also, if the platelet concentration is too low, the PRP-treated group would not Figure 6.”
BackgroundLiu, X., Zhang, R., Zhu, B., Li, Y., Liu, X., Guo, S., Wang, C., Wang, D., & Li, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10071 · Cited by 21
Metadata
- Authors
- Mazzocca, A. D., McCarthy, M. B. R., Chowaniec, D. M., Dugdale, E. M., Hansen, D., Cote, M. P., Bradley, J. P., Romeo, A. A., Arciero, R. A., & Beitzel, K.
- Venue
- The American Journal of Sports Medicine
- Publisher
- SAGE Publications
- Published
- 2012-07-16
- Volume
- 40
- Issue
- 8
- Pages
- 1742-1749
- ISSN
- 0363-5465 (ISSN-L)
- 1552-3365
- OpenAlex
- W2167432895
- Cited by
- 210
- References
- 3
- FWCI
- 20.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.